Oxypurine excretion in normal newborn infants

Area of Science:

• Biochemistry
• Neonatal Physiology
• Metabolic Studies

Background:

• Purine metabolism is crucial for cellular function and energy.
• Uric acid, hypoxanthine, and xanthine are key oxypurines in human metabolism.
• Understanding neonatal purine catabolism is vital for assessing metabolic health.

Purpose of the Study:

• To quantify the excretion of hypoxanthine, xanthine, and uric acid in newborn infants.
• To analyze changes in oxypurine excretion during the first three days of life.
• To investigate the dynamic shifts in purine catabolites in neonates.

Main Methods:

• Enzymatic spectrophotometry was used for compound determination.
• 24-hour urine samples were collected from 23 newborn infants.
• Excretion levels were measured daily for the first three postnatal days.

Main Results:

• Hypoxanthine excretion significantly decreased over the three days (p < 0.05).
• Xanthine excretion significantly increased over the three days (p < 0.05).
• The combined excretion of hypoxanthine and xanthine remained stable, comprising ~2.5% of total oxypurines.

Conclusions:

• Neonatal purine metabolism exhibits a significant shift from hypoxanthine to xanthine excretion within the first three days.
• This metabolic transition suggests adaptive changes in purine catabolic pathways post-birth.
• The findings provide baseline data for neonatal purine metabolism and potential clinical indicators.